Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity
Epilepsia · 2024
DOI: 10.1111/epi.18092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Hongbin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pharmacology and Pharmaceutical Analysis, School of Pharmacy, Qingdao University Medical College, Qingdao, China. Hauptthemen laut MEDLINE: Anticonvulsants, Phenylenediamines, Carbamates, KCNQ2 Potassium Channel. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Objective
Pharmacological activation of neuronal Kv7 channels by the antiepileptic drug retigabine (RTG; ezogabine) has been proven effective in treating partial epilepsy. However, RTG was withdrawn from the market due to the toxicity caused by its phenazinium dimer metabolites, leading to peripheral skin discoloration and retinal abnormalities. To address the undesirable metabolic properties of RTG and prevent the formation of phenazinium dimers, we made chemical modifications to RTG, resulting in a new RTG derivative, 1025c, N,N′ ‐{4‐[(4‐fluorobenzyl) (prop‐2‐yn‐1‐yl)amino]‐1,2‐phenylene}bis(3,3‐dimethylbutanamide).
Methods
Whole‐cell recordings were used to evaluate Kv7 channel openers. Site‐directed mutagenesis and molecular docking were adopted to investigate the molecular mechanism underlying 1025c and Kv7.2 interactions. Mouse seizure models of maximal electroshock (MES), subcutaneous pentylenetetrazol (scPTZ), and PTZ‐induced kindling were utilized to test compound antiepileptic activity.
Results
The novel compound 1025c selectively activates whole‐cell Kv7.2/7.3 currents in a concentration‐dependent manner, with half‐maximal effective concentration of .91 ± .17 μmol·L −1 . The 1025c compound also causes a leftward shift in Kv7.2/7.3 current activation toward a more hyperpolarized membrane potential, with a shift of the half voltage of maximal activation (ΔV 1/2 ) of −18.6 ± 3.0 mV. Intraperitoneal administration of 1025c demonstrates dose‐dependent antiseizure activities in assays of MES, scPTZ, and PTZ‐induced kindling models. Moreover, through site‐directed mutagenesis combined with molecular docking, a key residue Trp236 has been identified as critical for 1025c‐mediated activation of Kv7.2 channels. Photostability experiments further reveal that 1025c is more photostable than RTG and is unable to dimerize. Significance Our findings demonstrate that 1025c exhibits potent and selective activation of neuronal Kv7 channels without being metabolized to phenazinium dimers, suggesting its developmental potential as an antiseizure agent for therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pharmacology and Pharmaceutical Analysis, School of Pharmacy, Qingdao University Medical College, Qingdao, China.
- School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao, China.
- Qingdao Key Laboratory of Neurorehabilitation, University of Health and Rehabilitation Sciences, Qingdao, China.
- Institute of Innovative Drug Discovery, Qingdao University Medical College, Qingdao, China.
ORCID-Profile: Ningning Wei
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, H., Qiao, Z., Luan, K., Xiang, W., Chang, X., Zhang, Y., Wei, N., & Wang, K. (2024). Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity. Epilepsia. https://doi.org/10.1111/epi.18092
Vancouver
Wang H, Qiao Z, Luan K, Xiang W, Chang X, Zhang Y, et al. Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity. Epilepsia. 2024. doi:10.1111/epi.18092
BibTeX
@article{Wang2024,
author = {Wang, Hongbin and Qiao, Zhen and Luan, Kun and Xiang, Wei and Chang, Xiuying and Zhang, Yanru and Wei, Ningning and Wang, KeWei},
title = {Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.18092}
}
EUVIMED